Advances in pharmacogenetics and pharmacogenomics related to CINV should contribute to future personalized cancer therapy strategies.

Advances in pharmacogenetics and pharmacogenomics related to CINV should contribute to future personalized cancer therapy strategies.

This complexity makes it much more difficult for researchers to identify the specific connections between pharmacogenetics and race/ethnicity. In a recent study, Tang et al. (2005) analyzed ...

Dr. Swen is one of the primary investigators of the “Ubiquitous Pharmacogenomics” project (www.upgx.eu). U-PGx aims to implement pharmacogenetics across 7 European sites by genotyping 8,100 ...

It explores the role of pharmacogenetics developing an understanding of the molecular aspects of ... The course aims are to: Provide a detailed knowledge of genetics and pharmacogenomics in medicine.

The Clinical Pharmacology and Pharmacogenetics research groups at the Individualized Drug Therapy Research Program (INDIVIDRUG), University of Helsinki, work to identify key factors affecting drug ...

CIGBS recognizes that in planning for human studies, drug development programs require efficient application of pharmacokinetic and pharmacogenomics testing at critical steps of the process. Our ...

The chemotherapy drugs 5-FU and capecitabine could harm or kill you if you have a variant in the DPYD gene. Request genetic testing before you take these drugs.

Jun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura, MD, PhD, demonstrated that treatment and ...

Acute lymphoblastic leukemia (ALL) affects both children and adults, but children have better chances to be cured, with long-term survival rates over 85% compared to 50-75% in adults. Scientists ...

My clinical focuses are in psychopharmacology, pharmacogenetics, and treatment resistant conditions. In addition, I am a member of the American Society of Clinical Hypnosis and provide treatment ...